-
G-Quadruplexes, TDP-43 Condensation, and Toxicity
2026-08-12
Oldani et al. show that G-quadruplexes directly influence TDP-43 aggregation, localization, and toxicity across biochemical and cellular models. The study supports a structure-focused view of RNA–protein misfolding and suggests that manipulating G-quadruplex populations could modulate disease-relevant TDP-43 condensates, while remaining preclinical.
-
Sumatriptan as an Anti-Inflammatory Agent: Review
2026-08-12
This systematic review reframes sumatriptan, traditionally used for migraine and cluster headache, as a potential modulator of inflammatory signaling. By synthesizing 66 studies, it connects 5-HT1B/1D receptor activity with cytokine regulation, nitric oxide signaling, CGRP release, and protection in several experimental injury models.
-
Toremifene Citrate: Reliable Assay Workflows
2026-08-11
A scenario-driven guide to using Toremifene Citrate (SKU B1513) in estrogen receptor signaling, breast cancer research, and cell-based viability workflows. It connects receptor-level potency, solvent handling, concentration design, data interpretation, and vendor-selection criteria to improve experimental consistency.
-
Protease Inhibitor Cocktail for OXPHOS Assays
2026-08-11
Protect intact LRPPRC and OXPHOS-related proteins during cell and tissue extraction with an EDTA-free, broad-spectrum formulation. This workflow connects dependable sample preparation with mechanistic studies of LRPPRC inhibition and dasatinib synergy, while addressing co-IP, Western blot, kinase-assay, and tissue-extract challenges.
-
Topotecan HCl: From DNA Lesions to Translation
2026-08-10
Topotecan HCl offers translational researchers a mechanistically defined topoisomerase 1 inhibitor for linking replication-associated DNA damage with measurable tumor-cell outcomes. This thought-leadership perspective connects target biology, response kinetics, model selection, schedule design, comparative activity, and preclinical safety interpretation.
-
Metformin HCl and AMPK in Vocal Fold Fibrosis
2026-08-09
A translational analysis of how Metformin Hydrochloride engages AMPK-linked antifibrotic biology, what the vocal fold fibrosis evidence supports, and how researchers can design more decision-ready experiments.
-
Nigericin: pH Modulation for Translational Assays
2026-08-08
Nigericin gives researchers a practical way to perturb potassium–proton exchange, intracellular pH, and mitochondrial ion gradients in controlled cell-based assays. This guide translates that mechanism into oncology, mitochondrial, and carefully bounded antibiotic-potentiation workflows while emphasizing controls, solvent handling, and interpretation limits.
-
Nanoparticle mRNA Delivery to Reverse Trastuzumab Resistance
2026-08-07
Dong and colleagues developed a tumor-microenvironment-responsive nanoparticle system for intravenous delivery of PTEN mRNA to trastuzumab-resistant HER2-positive breast cancer models. The approach restored PTEN expression, inhibited persistently active PI3K/Akt signaling, and improved the ability of trastuzumab to suppress tumor growth, while also illustrating the formulation and delivery requirements for systemic in vitro transcribed mRNA therapy.
-
DeferoxamineB: Optimizing Iron Chelation for Cancer Research
2026-08-07
Deferoxamine (DeferoxamineB) stands at the crossroads of iron metabolism and regulated cell death, enabling precision modulation of ferroptosis and cuproptosis pathways in oncology models. This article translates the latest metabolic intervention breakthroughs into robust experimental workflows, actionable troubleshooting, and protocol upgrades that drive reproducible, high-impact results.
-
Cy5 amine (non-sulfonated): Technical Use and Protocol Guida
2026-08-06
Cy5 amine (non-sulfonated) addresses the need for a bright, photostable, water-insoluble fluorescent probe for covalent biomolecule labeling in controlled, non-aqueous environments. It is not intended for direct aqueous conjugation, diagnostic, or clinical use, and requires careful handling in organic solvents for efficient labeling reactions.
-
Serotonin Inhibits HRP-Mediated Biotin-LC-LC-Tyramide Labeli
2026-08-06
A recent study reveals that serotonin, but not dopamine, specifically inhibits horseradish peroxidase (HRP)-mediated protein biotinylation using membrane-impermeant biotin-LC-LC-tyramide probes. The research provides a mechanistic explanation and offers a chemical strategy to restore labeling efficiency, informing future cell surface proteomics in serotonergic systems.
-
Anti-ROR1 Antibody (Zilovertamab): Applied Workflows & Assay
2026-08-05
Harness the precision of Anti-ROR1 Antibody (Zilovertamab) from APExBIO for robust inhibition of Wnt5a-induced ROR1 signaling in advanced cancer and toxicology models. This guide translates cutting-edge mechanistic insights into actionable protocols, troubleshooting strategies, and workflow enhancements for translational research.
-
Toremifene Citrate in Breast Cancer Research: Protocols & Pr
2026-08-05
Toremifene Citrate stands at the forefront of hormone receptor modulation, offering robust, reproducible inhibition of estrogen-driven proliferation in breast cancer models. This article delivers hands-on protocol guidance, troubleshooting strategies, and evidence-based insights that elevate experimental reliability and translational value.
-
Direct Mouse Genotyping Kit: Precision Control for RNA Splic
2026-08-04
Explore how the Direct Mouse Genotyping Kit enables rapid, purification-free PCR directly from mouse tissue, empowering advanced genetic screening and precise investigation of RNA splicing mechanisms. This article uniquely connects high-throughput mouse genotyping to current breakthroughs in spliceosome research.
-
Ruxolitinib (INCB018424): Potent JAK1/2 Inhibitor in Researc
2026-08-04
Ruxolitinib (INCB018424) is a highly selective ATP-competitive inhibitor of JAK1 and JAK2, enabling precise modulation of the JAK-STAT pathway in myeloproliferative disorder research. Its nanomolar potency and robust immunomodulatory profile are well-validated in both in vitro and in vivo models, as supported by independent and product-based evidence.